Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

ASCO® 2023 Insights: "PERSIST-2 Landmark OS Analysis - Spleen Volume Reduction Predicts OS in Myelofibrosis Pts on Pacritinib, But Not Best Available Therapy"

318 views
June 9, 2023
Comments 0
Login to view comments. Click here to Login